Makers Laboratories credit ratios

Profitability Growth Credit Liquidity Working capital Dividend yield DuPont CAGR

Per cent unless marked ×

Tap a line for its trend	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023

2.7	0.3	13.6	9.2
2.7	0.3	13.5	9.2
0.05×	0.01×	0.26×	0.16×
0.05×	0.00×	0.26×	0.16×
3.70×	−0.13×	−3.61×	−2.24×
3.66×	−0.12×	−3.59×	−2.22×
−3.91×	−5.38×	−3.96×	−4.73×
4.7%	0.5%	20.9%	13.7%

Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

alphave

MAKERSL₹192.45

Makers Laboratories Limited

· Pharma & Health

₹ CrorePeersBPLPHARMA JENBURPH KPL NOVARTIND PARNAXLAB SGRL SHUKRAPHAR SUNLOCMcap ₹114 Cr

Profitability Growth Credit Liquidity Working Capital Yield Analysis DuPont

Ratios — % unless marked × 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026
Total Debt	9.2	13.6	0.3	2.7
Net Debt	9.2	13.5	0.3	2.7
Total Debt/Equity	0.16	0.26	0.01	0.05
Net Debt/Equity	0.16	0.26	0.00	0.05
Total Debt/EBITDA	-2.24	-3.61	-0.13	3.70
Net Debt/EBITDA	-2.22	-3.59	-0.12	3.66
Interest Coverage (EBIT/Interest)	-4.73	-3.96	-5.38	-3.91
Total Debt/Total Capital %	13.69	20.89	0.53	4.73

No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 85%.